Merck Executive and Leadership Team

Rungrawee Selananda, the Chief Financial Officer & Member of Board Executive at Merck, directs the global financial strategy and capital allocation processes. Selananda oversees fiscal planning, risk management, and investor relations to ensure long-term economic stability across the multinational pharmaceutical and chemical portfolio. By analyzing market trends in Europe, Asia, and the Americas, the Chief Financial Officer & Member of Board Executive provides critical insights for board-level decision-making regarding mergers, acquisitions, and research investments. Rungrawee Selananda maintains strict control over budgetary compliance and financial reporting standards, ensuring transparency for all stakeholders. This leadership position involves balancing immediate operational costs with the high capital requirements of long-term drug discovery. Through rigorous financial modeling and strategic oversight, the Chief Financial Officer & Member of Board Executive secures the necessary resources to sustain the company mission of scientific advancement and market growth.

Kevin McCafferty, the President USW 10-00086 at Merck, oversees labor relations and operational coordination within the specific manufacturing and chemical production sectors. McCafferty directs the alignment of workforce activities with the broader corporate objectives of the pharmaceutical and chemical divisions. By managing the interface between production teams and management, the President USW 10-00086 ensures that manufacturing processes meet the high quality and safety standards required for global distribution. Kevin McCafferty maintains oversight of operational efficiency, focusing on the optimization of chemical production workflows. This leadership role involves navigating complex labor environments to maintain consistent output and supply chain reliability. Through the implementation of collaborative management practices, the President USW 10-00086 supports the stability of the manufacturing base. Ultimately, the President USW 10-00086 ensures that the production facilities remain capable of meeting the rigorous demands of the international life sciences market.

Rogier Janssens, the President, Merck (China) at Merck, directs all business operations and strategic growth initiatives within the Chinese market. Janssens oversees the integration of pharmaceutical, chemical, and life sciences divisions to capture emerging opportunities in this critical region. By managing relationships with local regulatory bodies and healthcare partners, the President, Merck (China) ensures that the company maintains a competitive edge in the rapidly evolving Asian landscape. Rogier Janssens coordinates with global research centers, particularly the facility in Beijing, to align local innovation with international standards. This leadership role involves driving market expansion through localized product strategies and operational excellence. Through the execution of comprehensive business plans, the President, Merck (China) secures the company position as a key provider of advanced scientific solutions. Ultimately, the President, Merck (China) facilitates the growth of the regional footprint while upholding the core mission of scientific excellence.

Anita Zubak, the Development Sciences & Clinical Supplies Chief of Staff (Dscs) at Merck, manages the operational infrastructure supporting complex pharmaceutical research pipelines. Zubak coordinates cross-functional workflows between clinical supply chains and laboratory research teams to accelerate drug development timelines. By optimizing resource allocation across major research centers in Europe and the Americas, the Chief of Staff ensures alignment with rigorous regulatory standards. Anita Zubak maintains oversight of internal project management systems, facilitating seamless communication between scientific departments and executive leadership. This role demands precise synchronization of clinical trial materials and data integrity protocols. Through the implementation of streamlined operational frameworks, the Chief of Staff enhances the efficiency of the entire development lifecycle. Ultimately, the Chief of Staff drives the successful delivery of critical therapeutic candidates to global clinical trials, reinforcing the company position as a leader in life sciences innovation.

Elisaul Hernandez, the Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America at Merck, architects the commercial strategy for oncology products while managing regional business operations. Hernandez drives market penetration for life-saving cancer therapies by aligning clinical value propositions with patient needs across Latin American markets. By coordinating with global research teams, the Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America ensures that regional commercial activities reflect the latest scientific breakthroughs. Elisaul Hernandez oversees the execution of go-to-market strategies, optimizing distribution networks and healthcare provider engagement. This dual-focus role requires deep integration of oncology-specific marketing tactics with broader operational management. Through the implementation of data-driven growth initiatives, the Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America expands the reach of the company portfolio, directly impacting patient outcomes and regional revenue targets.

Iman Griffin, the Global Diversity & Inclusion Center of Excellence Chief of Staff at Merck, directs the strategic implementation of inclusive workplace policies across the multinational organization. Griffin manages the operational framework for diversity initiatives, ensuring that talent acquisition and employee development programs align with the company commitment to a global, equitable culture. By collaborating with regional leadership in Europe, Africa, and Asia, the Global Diversity & Inclusion Center of Excellence Chief of Staff integrates diverse perspectives into the core business model. Iman Griffin oversees the tracking of key performance indicators related to workforce representation and organizational health. This leadership role involves facilitating communication between the Center of Excellence and executive management to drive cultural transformation. Through the execution of targeted inclusion strategies, the Global Diversity & Inclusion Center of Excellence Chief of Staff fosters an environment that supports innovation and attracts top-tier scientific talent from around the world.

Jaipurcfa Merck, the Cfa at Merck, manages specialized financial analysis and investment oversight for the company chemical and pharmaceutical portfolios. Jaipurcfa Merck directs the evaluation of market risks and asset performance to support informed strategic decision-making. By providing granular financial insights, the Cfa assists executive leadership in optimizing capital allocation across the diverse business units. Jaipurcfa Merck maintains rigorous standards for financial reporting and compliance, ensuring that all investment activities align with the long-term goals of the organization. This role involves analyzing the economic impact of research and development expenditures on the overall corporate balance sheet. Through the application of advanced financial methodologies, the Cfa enhances the precision of fiscal planning. Ultimately, the Cfa supports the financial health of the company by identifying opportunities for efficiency and growth within the competitive global landscape of the life sciences and chemical industries.